- Division of Clinical Pharmacology at the Hospital of the Ludwig-Maximilians-Universität in Munich
- Start date
- as soon as possible
- Application deadline
- 30 Apr 2021
The Division of Clinical Pharmacology at the Hospital of the Ludwig-Maximilians-Universität in Munich invites applications for two research positions within the European Innovation Training Network for Optimizing Adoptive T cell Therapy of Cancer – T-OP.
T-OP is a research network of 12 academic research groups, four industrial partners and one public authority in seven European countries. The joint goal is to train the next generation of scientists in the field of adoptive T cell therapy (ACT) of cancer. The research objective of T-OP is to optimize the use of cytokine support in ACT, as it is a key element of these products. T-OP brings together interdisciplinary and cross-sectorial teams spanning large and small-sized companies as well as experts in different aspects of cell therapy, immunology, protein engineering and bioinformatics. Please find further information at www.itn-top.eu
Tasks and responsibilities
The scientific projects of two Early Stage Researchers (PhD students) (supervised by Prof. Dr. med. Sebastian Kobold) are:
- “Analysis of the influence of cytokine stimulation on ACT safety”
- “Chimeric cytokine receptors for ACT of cancer”
- Excellent scientists with a master degree or equivalent in natural sciences or related disciplines (such as medicine or pharmacy); practical skills in modern laboratory work, preferentially combined with experience in animal experiments.
- You must be within your first four years of research experience after completion of your Master’s degree or equivalent; you cannot hold a doctoral degree at the time of recruitment; you cannot have spent more than 12 months within the past 36 months in Germany (mobility rule); you must be proficient in the English language both written and spoken (proof required).
Two positions for cutting edge research projects and training with leading experts in the field of immunotherapy of cancer; employment contract for three years with the benefits of the EU Marie Skłodowska-Curie program.
People with disabilities who are equally as qualified as other applicants will receive preferential treatment.
The application procedure will be carried out in compliance with the Code of Conduct for Recruitment and the Charter for Researchers.
Please send your application until Friday April 30th, 2021 to:
We look forward to your application.
Where knowledge is everything. Become part of LMU Munich!
LMU researchers work at the highest level on the great questions affecting people, society, culture, the environment and technology — supported by experts in administration, IT and tech.
LMU offers state-of-the-art research infrastructure, an outstanding international network, attractive career opportunities and a broad spectrum of continuing personal development programs. In doing so, LMU supports its members in nurturing their talents and helping to shape their working environment.